Upstream Bio (UPB) Receivables - Net (2023 - 2025)
Upstream Bio has reported Receivables - Net over the past 3 years, most recently at $668000.0 for Q4 2025.
- Quarterly results put Receivables - Net at $668000.0 for Q4 2025, up 8.97% from a year ago — trailing twelve months through Dec 2025 was $668000.0 (up 8.97% YoY), and the annual figure for FY2025 was $668000.0, up 8.97%.
- Receivables - Net for Q4 2025 was $668000.0 at Upstream Bio, down from $683000.0 in the prior quarter.
- Over the last five years, Receivables - Net for UPB hit a ceiling of $937000.0 in Q2 2025 and a floor of $98000.0 in Q4 2023.
- Median Receivables - Net over the past 3 years was $610000.0 (2024), compared with a mean of $559000.0.
- Biggest five-year swings in Receivables - Net: soared 525.51% in 2024 and later rose 8.97% in 2025.
- Upstream Bio's Receivables - Net stood at $98000.0 in 2023, then soared by 525.51% to $613000.0 in 2024, then increased by 8.97% to $668000.0 in 2025.
- The last three reported values for Receivables - Net were $668000.0 (Q4 2025), $683000.0 (Q3 2025), and $937000.0 (Q2 2025) per Business Quant data.